Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system

Medical Care

Volumn 40, Issue 2, 2002, Pages 113-128

  Feeny, David ^a,b,f   Furlong, William ^b,e   Torrance, George W ^b   Goldsmith, Charles H ^c,e   Zhu, Zenglong ^d   DePauw, Sonja ^e   Denton, Margaret ^e   Boyle, Michael ^e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Health Utilities Incorporated   (Canada)

^c CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^d PRUDENTIAL FINANCIAL   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f INSTITUTE OF HEALTH ECONOMICS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CLASSIFICATION; HEALTH SERVICES RESEARCH; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERVIEW; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; AGED; HEALTH SERVICES RESEARCH; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INTERVIEWS; MIDDLE AGED; MODELS, STATISTICAL; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT;

EID: 0036479487     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200202000-00006     Document Type: Article

References (32)

1. Furlong WJ, Feeny D, Torrance GW, et al. The health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375-384.
2. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems: health utilities index. Pharmacoeconomics 1995;7:490-502.
3. Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Press; 1996:85-95.
4. Furlong W, Feeny D, Torrance GW, et al. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark 3 (HUB) System: A Technical Report. Hamilton, Ontario: McMaster University Centre for Health Economics and Policy Analysis Working Paper No. 98-11, 1998. Paper is available as a read only file at http://www.fhs.mcmaster.ca/hug/index.htm or at http://www.healthutilities.com
5. Torrance GW. Measurement of health state utilities for economic appraisal - a review. J Health Econ 1986;5:1-30.
6. Feeny D, Torrance GW. Incorporating utility-based quality-of-life assessments in clinical trials: two examples. Med Care 1989;27:S190-S204.
7. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-575.
8. Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: health utilities index. Pharmacoeconomics 1995;7:503-520.
9. Feeny D. The utility approach to assessing health-related quality of life. Med Care 2000;38:II-151-II-154.
10. Furlong W, Feeny D, Torrance GW, et al. Guide to Design and Development of Health-State Utility Instrumentation. Hamilton, Ontario: McMaster University Centre for Health Economics and Policy Analysis, CHEPA Working Paper 90-9, 1990.
11. Luce RD, Raiffa H. Games and Decisions: Introduction and Critical Survey. New York, NY: John Wiley & Sons, Inc.; 1957.
12. von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton, NJ: Princeton University Press; 1944.
13. Keeney RL. Building Models of Values. Eur J Oper Res 1988;37:149-157.
14. Keeney RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs. 2nd ed. New York, NY: Cambridge University Press; 1993.
15. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982;30:1042-1069.
16. Torrance GW, Feeny DH, Furlong WJ, et al. Multi-Attribute Preference Functions for A Comprehensive Health Status Classification System: Health Utilities Index Mark 2. Med Care 1996;34:702-722.
17. United States Department of Commerce. Fractional Factorial Experiment Designs for Factors at Two Levels. Washington, DC: National Bureau of Standards, Applied Mathematics Series No. 48, US Government Printing Office; 1957.
18. Statistics Canada. Health Status of Canadians: Report of the 1991 General Social Survey. Ottawa: Statistics Canada, Catologue 11-612E, No. 8, March, 1994.
19. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. 1st ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1994.
20. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1997.
21. Gold MR, Siegel JE, Russell LB, et al, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
22. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY: Oxford University Press; 1993.
23. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. 2nd ed. Oxford: Oxford University Press; 1995.
24. Torrance GW, Feeny D, Furlong W. Visual analogue scales: do they have a role in the measurement of preferences for health states? Med Decis Making 2001;21:329-334.
25. Torrance GW, Zhang Y, Feeny D, et al. Multi-Attribute Preference Functions for A Comprehensive Health Status Classification System. McMaster University, Centre for Health Economics and Policy Analysis Working Paper No. 92-18, 1992.
26. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Controlled Clin Trials 1991;12:142S-158S.
27. Little, RJA, Rubin DB. Statistical Analysis with Missing Data. New York, NY: J. Wiley and Sons; 1987.
28. Feeny DH, Torrance G, Goldsmith C, et al. Health utilities index mark 3: multi-linear multi-attribute utility function. Qual Life Res 1999;8:600 (abstract).
29. Neumann PJ, Sandberg EA, Araki SS, et al. A comparison of hui2 and hui3 utility scores in alzheimer's disease. Med Decis Making 2000;20:413-422.
30. Menon D, Schubert F, Torrance GW. Canada's new guidelines for the economic evaluation of pharmaceuticals. Med Care 1996;34:DS77-DS86.
31. Torrance GW, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Pharmacoeconomics 1996;9:535-559.
32. Siegel JE, Torrance GW, Russell LB, et al. Guidelines for pharmacoeconomic studies: recommendations from the panel on cost effectiveness in health and medicine. Pharmacoeconomics 1997;11:159-168.